Preparation of multiple-unit floating-bioadhesive cooperative minitablets for improving the oral bioavailability of famotidine in rats

Abstract The aims of this study were to prepare fine famotidine-containing floating-bioadhesive cooperative minitablets and to investigate the possibility of using those minitablets as a delivery system for promoting the oral bioavailability of famotidine. Nine minitablet formulations were designed using hydroxypropylmethylcellulose (HPMC K4M) as release-retarding polymers, Carbopol 971P as bioadhesive materials and sodium bicarbonate (NaHCO3) as gas formers. The prepared 3 ± 0.02 mm minitablets were evaluated in terms of their swelling ability, floating behavior, bioadhesion test and in vitro release. The optimized minitablets (F6) containing HPMC K4M (50.00%, w/w), Carbopol 971P (10.00%, w/w) and NaHCO3 (10.00%, w/w) were found to float in 1 min and remain lastingly buoyant over a period of 8 h in vitro, with excellent bioadhesive properties (20.81 g) and sustained drug release characteristics (T50% = 46.54%) followed one-order model. In addition, plasma concentration–time profiles from pharmacokinetic studies in rats dosed with minitablets showed 1.62-fold (p < 0.05) increased absorption of famotidine, compared to the market tablets XinFaDing®. These studies demonstrated that the multiple-unit floating-bioadhesive cooperative minitablets may be a promising gastro-retentive delivery system for drugs that play a therapeutic role in the stomach.

[1]  D. L. Munday,et al.  Controlled release delivery: Effect of coating composition on release characteristics of mini-tablets , 1989 .

[2]  P. Dallas,et al.  FLOATING AND SWELLING CHARACTERISTICS OF VARIOUS EXCIPIENTS USED IN CONTROLLED RELEASE TECHNOLOGY , 1993 .

[3]  P. Costa,et al.  Modeling and comparison of dissolution profiles. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  C. Graffner,et al.  Intra- and intersubject variation of erythromycin absorption from single-unit and multiple-unit enteric-coated products. , 1986, Biopharmaceutics & drug disposition.

[5]  V. Kadam,et al.  Development and in vitro evaluation of an oral floating matrix tablet formulation of diltiazem hydrochloride , 2007, AAPS PharmSciTech.

[6]  J. Siepmann,et al.  HPMC-Matrices for Controlled Drug Delivery: A New Model Combining Diffusion, Swelling, and Dissolution Mechanisms and Predicting the Release Kinetics , 1999, Pharmaceutical Research.

[7]  P. Sriamornsak,et al.  Swelling, erosion and release behavior of alginate-based matrix tablets. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  C. Tuleu,et al.  Minitablets: New Modality to Deliver Medicines to Preschool-Aged Children , 2009, Pediatrics.

[9]  K. Pintye-Hódi,et al.  Evaluation of powder mixtures and hydrophilic gastroretentive drug delivery systems containing zinc acetate and sodium bicarbonate. , 2011, Journal of pharmaceutical and biomedical analysis.

[10]  Y. Tabata,et al.  Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[11]  J. B. Mielck,et al.  Minitabletting: improving the compactability of paracetamol powder mixtures , 1998 .

[12]  R. R. Jivani,et al.  Design and Development of a Self Correcting Monolithic Gastroretentive Tablet of Baclofen , 2009 .

[13]  F. A. Mohammed,et al.  Preparation and In Vitro/In Vivo Evaluation of the Buccal Bioadhesive Properties of Slow-Release Tablets Containing Miconazole Nitrate , 2003, Drug development and industrial pharmacy.

[14]  D. Nyholm,et al.  An automatic dose dispenser for microtablets--a new concept for individual dosage of drugs in tablet form. , 2003, International journal of pharmaceutics.

[15]  A. Bernkop‐Schnürch.  Mucoadhesive systems in oral drug delivery. , 2005, Drug discovery today. Technologies.

[16]  V. Iannuccelli,et al.  Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation , 1998 .

[17]  M. I. Tadros.  Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: development, optimization and in vitro-in vivo evaluation in healthy human volunteers. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  K. Amighi,et al.  Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. , 2007, International journal of pharmaceutics.

[19]  G. Buckton,et al.  Probing the mechanisms of swelling of hydroxypropylmethylcellulose matrices , 1993 .

[20]  Y. Kawashima,et al.  In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. , 2004, International journal of pharmaceutics.

[21]  F. Atyabi,et al.  In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins , 1996 .

[22]  Matthew Roberts,et al.  Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets , 2012, Drug development and industrial pharmacy.

[23]  Ravi Kumar,et al.  Formulation and Evaluation of Effervescent Floating Tablet of Famotidine , 2009 .

[24]  B. Mishra,et al.  Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. , 1999, Drug development and industrial pharmacy.

[25]  R. Cargill,et al.  Controlled Gastric Emptying. III. Gastric Residence Time of a Nondisintegrating Geometric Shape in Human Volunteers , 1993, Pharmaceutical Research.

[26]  Y. Tanwar,et al.  Formulation and evaluation of famotidine floating tablets. , 2007, Current drug delivery.

[27]  R. Gröning,et al.  Oral Dosage Forms with Controlled Gastrointestinal Transit , 1984 .

[28]  E. Cedillo-Ramírez,et al.  Effect of Added Pharmatose DCL11 on the Sustained-Release of Metronidazole From Methocel K4M and Carbopol 971P NF Floating Matrices , 2006, Drug development and industrial pharmacy.

[29]  P. Vavia,et al.  Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. , 2006, International journal of pharmaceutics.

[30]  R. Gröning,et al.  Dosage forms with controlled gastrointestinal passage — studies on the absorption of nitrofurantoin , 1989 .

[31]  Paulo Costa,et al.  Directly Compressed Mini Matrix Tablets Containing Ibuprofen: Preparation and Evaluation of Sustained Release , 2006, Drug development and industrial pharmacy.

[32]  Jianjun Zhang,et al.  Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. , 2011, International journal of pharmaceutics.

[33]  D. L. Munday.  A Comparison of the Dissolution Characteristics of Theophylline from Film Coated Granules and Mini-Tablets , 1994 .

[34]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[35]  R. Bodmeier,et al.  In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.